Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision label was updated to v3.6.4, signaling a software update to the ClinicalTrials.gov page. This update is a backend/UI tweak and does not modify the study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated to v3.6.3, signaling a current version of the page. This update appears to be a metadata/version bump without changes to the study details, locations, or eligibility criteria.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a software update. No changes to the displayed study information or navigation are evident.SummaryDifference0.0%

- Check56 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. Added help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and updated the page revision from v3.5.5 to v3.6.0, removing the old Intervention / Treatment heading.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page revision changed from v3.5.4 to v3.5.5. This indicates a minor backend/build update rather than a change to content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small update to the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.